Marta Bondanelli Selected Research

Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)

12/2007	Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.
10/2005	Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Bondanelli Research Topics

Disease

10	Acromegaly 01/2023 - 03/2002
8	Thyroid Neoplasms (Thyroid Cancer) 05/2012 - 10/2002
7	Neoplasms (Cancer) 01/2018 - 10/2002
4	Pituitary Neoplasms (Pituitary Adenoma) 05/2008 - 01/2006
3	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2006 - 06/2003
2	Thyroid Nodule (Nodule, Thyroid) 05/2022 - 08/2005
2	Hyperprolactinemia 01/2021 - 10/2006
2	Rare Diseases (Rare Disease) 01/2020 - 01/2018
2	Hypertension (High Blood Pressure) 10/2008 - 12/2006
2	Lymphatic Metastasis 03/2005 - 02/2005
1	Graves Ophthalmopathy 03/2024
1	AIDS-Related Complex (ARC) 03/2024
1	Graves Disease (Basedow Disease) 03/2024
1	Hyperemia 01/2024
1	Inappropriate ADH Syndrome (SIADH) 11/2023
1	Hyponatremia 11/2023
1	Insulin Resistance 05/2022
1	Hypercalciuria 01/2022
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2022
1	Adenoma (Adenomas) 01/2020
1	beta-Thalassemia (Cooley's Anemia) 01/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Developmental Bone Diseases (Bone Dysplasia) 01/2019
1	Iron Overload 01/2018
1	Hypoparathyroidism 01/2018
1	Adenocarcinoma 06/2017
1	ACTH-Secreting Pituitary Adenoma 01/2016
1	Osteoporosis 10/2013
1	Hypocalcemia 10/2013
1	Femoral Fractures (Femoral Fracture) 10/2013
1	Carcinogenesis 10/2009
1	Critical Illness (Critically Ill) 01/2008
1	Breast Neoplasms (Breast Cancer) 12/2007
1	Ischemic Stroke 10/2006
1	Stroke (Strokes) 10/2006
1	Gigantism 09/2005
1	Papillary Thyroid Cancer 08/2005
1	Carcinoid Tumor (Carcinoid) 04/2005
1	Neoplasm Metastasis (Metastasis) 04/2005
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2004
1	Hypothyroidism 06/2004

Drug/Important Bio-Agent (IBA)

7	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023 - 08/2005
7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 03/2002
5	Growth Hormone (Somatotropin)IBA 01/2020 - 10/2002
5	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2014 - 10/2002
4	Hormones (Hormone)IBA 05/2008 - 10/2002
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2005
3	CalciumIBA 01/2022 - 10/2013
2	Parathyroid Hormone (Parathormone)IBA 01/2022 - 01/2018
2	Insulin (Novolin)FDA Link 01/2020 - 10/2002
2	LigandsIBA 02/2014 - 03/2007
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2008 - 10/2006
2	Glycoproteins (Glycoprotein)IBA 12/2007 - 10/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2007 - 10/2005
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2007 - 10/2005
2	lanreotide (Somatuline)FDA Link 04/2005 - 03/2002
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2005 - 02/2005
2	Thyroglobulin FDA Link 03/2005 - 02/2005
2	Thyrotropin Alfa FDA LinkGeneric 03/2005 - 02/2005
1	Methylprednisolone FDA LinkGeneric 03/2024
1	Vasopressins (Vasopressin)IBA 11/2023
1	Tolvaptan FDA Link 11/2023
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 05/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	AntibodiesIBA 01/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2019
1	MineralsIBA 01/2019
1	IronIBA 01/2019
1	CopperIBA 01/2018
1	Chromogranin AIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 06/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2017
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 06/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2017
1	Protein Kinase C-deltaIBA 01/2016
1	Growth Factor ReceptorsIBA 01/2016
1	Diphosphonates (Bisphosphonates)IBA 10/2013
1	enzastaurinIBA 05/2012
1	Protein Kinase CIBA 05/2012
1	Antihypertensive Agents (Antihypertensives)IBA 10/2008
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2007
1	pasireotideIBA 03/2007
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2006
1	SodiumIBA 12/2006
1	Testosterone (Sustanon)FDA Link 10/2006
1	GonadotropinsIBA 10/2006
1	Arginine (L-Arginine)FDA Link 10/2006
1	somatostatin receptor type 1IBA 06/2006
1	Protein Isoforms (Isoforms)IBA 10/2005
1	pentetreotide (OctreoScan)FDA Link 04/2005
1	ProlactinIBA 06/2004
1	AndrogensIBA 06/2003
1	GalaninIBA 03/2003

Therapy/Procedure

7	Therapeutics 06/2017 - 03/2002
2	Thyroidectomy 03/2005 - 02/2005
1	Image-Guided Radiotherapy 03/2024
1	Radiotherapy 03/2024
1	Critical Care (Surgical Intensive Care) 01/2024
1	Aftercare (After-Treatment) 10/2008